Skip to main content
Enrolls healthcare staffAgingDigital healthLongevityBehavioralBehavioral

What this study is

This project will compare two training models of an evidence-based online dementia care training program for direct care staff in assisted living to a waitlist control: 1) essentiALZ training and 2) essentiALZ training + Project ECHO. It will examine the extent to which each model is implemented and achieves its intended outcomes to improve staff knowledge and attitudes, change care practices, and improve the wellbeing of staff, residents, and residents' family members. Results will inform next steps in dementia care training for the assisted living (AL) and broader long-term care workforce.

To examine these outcomes, data will be collected from AL staff and families over the course of 6 months. Staff will complete questionnaires and participate in interviews (as applicable) at baseline, post-training, 3-months, and 6-months. Families will participate in interviews at baseline, 3-months, and 6-months.

What's being tested

  • essentiALZ

    Intervention · BEHAVIORAL

    essentiALZ is a web-based training that contains three hours of self-paced content separated into five modules, plus a final review. Modules include: 1) Alzheimer's disease and dementia; 2) person-centered care; 3) assessment and care planning; 4) activities of daily living; and 5) behaviors and communication. Staff will be encouraged to take the training over the course of four weeks.

  • Project ECHO

    Intervention · BEHAVIORAL

    ECHO is a virtual tele-mentoring model grounded in case-based learning. It includes six weekly one-hour sessions of didactic and discussive learning. The first five sessions will reflect the content of the five essentiALZ modules, and the final session will address maintenance. ECHO sessions are group sessions that will be conducted via Zoom.

Study details

Sponsor
University of North Carolina, Chapel Hill
Conditions
Aging · Knowledge, Attitudes, Practice · Long-Term Care · Dementia
Enrolling
1,764 people
Starts
2024-04-12
Est. completion
2027-02-28
Design
Single-blind, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗